BIALX
Price
$28.65
Change
+$0.02 (+0.07%)
Updated
Jul 31 closing price
Net Assets
2.2B
CNPAX
Price
$72.71
Change
+$0.65 (+0.90%)
Updated
Jul 31 closing price
Net Assets
170.23B
Interact to see
Advertisement

BIALX vs CNPAX

BIALX vs CNPAX Comparison Chart in %
View a ticker or compare two or three
VS
BIALX vs. CNPAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIALX is a Buy and CNPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. BIALX (2.2B). CNPAX pays higher dividends than BIALX: CNPAX (0.97) vs BIALX (0.32). BIALX was incepted earlier than CNPAX: BIALX (11 years) vs CNPAX (24 years). BIALX (0.91) is less costly to investors than CNPAX (0.74). CNPAX (23.00) and BIALX (22.00) have comparable annual turnover. BIALX has a lower initial minimum investment than CNPAX: BIALX (100) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 6.66 vs. BIALX (-3.05). BIALX return over 5 years is better than : 25.87 vs. CNPAX (12.85).
BIALXCNPAXBIALX / CNPAX
Total Expense Ratio0.910.74123%
Annual Report Gross Expense Ratio0.910.74123%
Fund Existence11 years24 years-
Gain YTD-1.5464.921-31%
Front LoadN/A4%-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B170B1%
Annual Yield % from dividends0.320.9733%
Returns for 1 year-3.056.66-46%
Returns for 3 years29.6133.4688%
Returns for 5 years25.8712.85201%
Returns for 10 years190.16113.25168%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PXJ42.531.04
+2.51%
Invesco Oil & Gas Services ETF
LRGE83.741.02
+1.23%
ClearBridge Large Cap Growth Select ETF
MJSC59.950.10
+0.16%
MUFG Japan Small Cap Active ETF
PLTZ30.13-0.46
-1.50%
Defiance Daily Target 2X Short PLTR ETF
FBT245.06-7.60
-3.01%
First Trust NYSE Arca Biotech ETF